unknown
Stage
1
Investors
About
b-12 develops AI-powered software and services to design, optimize, and execute complex chemical syntheses, accelerating pharmaceutical research and development by automating retrosynthesis planning, reaction optimization, and lab automation.
Explore b-12's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.